NCT05981196 Disparities Among Liver Transplant Patients
| NCT ID | NCT05981196 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | End Stage Liver DIsease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-11-15 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-11-15 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
Eligibility Criteria
Inclusion Criteria: \- Patients with end-stage liver, kidney, or cardiac dysfunction. Exclusion Criteria: * Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant. * Patients with potential medical exclusions for transplant.
Contact & Investigator
Gabrielle Montefiore
📞 480-574-1288
Peter E. Frasco, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05981196 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying End Stage Liver DIsease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05981196 currently recruiting?
Yes, NCT05981196 is actively recruiting participants. Visit ClinicalTrials.gov or contact Mayo Clinic to inquire about joining.
Where is the NCT05981196 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT05981196 clinical trial?
NCT05981196 is sponsored by Mayo Clinic. The principal investigator is Peter E. Frasco, MD at Mayo Clinic. The trial plans to enroll 100 participants.